Suppr超能文献

相似文献

5
Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.
Virchows Arch. 2011 Sep;459(3):299-306. doi: 10.1007/s00428-011-1127-5. Epub 2011 Jul 20.
6
Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
Diagn Mol Pathol. 2011 Sep;20(3):129-37. doi: 10.1097/PDM.0b013e31820e9c67.
8
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.
Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.
10
TMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.
Int J Clin Exp Pathol. 2015 Mar 1;8(3):2690-9. eCollection 2015.

引用本文的文献

1
Generation of Dual-Color FISH probes targeting 9p21, Xp21, and 17p13.1 loci as diagnostic markers for some genetic disorders and cancer in Egypt.
J Genet Eng Biotechnol. 2025 Mar;23(1):100449. doi: 10.1016/j.jgeb.2024.100449. Epub 2024 Dec 18.
2
Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma.
Exp Mol Med. 2024 Aug;56(8):1807-1815. doi: 10.1038/s12276-024-01291-2. Epub 2024 Aug 1.
4
TFE3 gene rearrangement and protein expression contribute to a poor prognosis of renal cell carcinoma.
Heliyon. 2023 May 6;9(5):e16076. doi: 10.1016/j.heliyon.2023.e16076. eCollection 2023 May.
5
MiT/TFE Family Renal Cell Carcinoma.
Genes (Basel). 2023 Jan 5;14(1):151. doi: 10.3390/genes14010151.
6
A review of neoplasms with MITF/MiT family translocations.
Histol Histopathol. 2022 Apr;37(4):311-321. doi: 10.14670/HH-18-426. Epub 2022 Feb 2.
7
Integrative clinical and molecular characterization of translocation renal cell carcinoma.
Cell Rep. 2022 Jan 4;38(1):110190. doi: 10.1016/j.celrep.2021.110190.
10
Renal Cell Carcinoma in the Era of Precision Medicine: From Molecular Pathology to Tissue-Based Biomarkers.
J Clin Oncol. 2018 Oct 29;36(36):JCO2018792259. doi: 10.1200/JCO.2018.79.2259.

本文引用的文献

1
Imatinib and beyond--exploring the full potential of targeted therapy for CML.
Nat Rev Clin Oncol. 2009 Sep;6(9):535-43. doi: 10.1038/nrclinonc.2009.112. Epub 2009 Aug 4.
2
Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma.
Am J Surg Pathol. 2009 Sep;33(9):1416-20. doi: 10.1097/PAS.0b013e3181a9cd6c.
3
Hereditary kidney cancer: unique opportunity for disease-based therapy.
Cancer. 2009 May 15;115(10 Suppl):2252-61. doi: 10.1002/cncr.24230.
5
Primary alveolar soft part sarcoma of fibula demonstrating ASPL-TFE3 fusion: a case report and review of the literature.
Skeletal Radiol. 2008 Nov;37(11):1047-51. doi: 10.1007/s00256-008-0540-6. Epub 2008 Jul 2.
7
Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
Int J Surg Pathol. 2008 Jan;16(1):66-72. doi: 10.1177/1066896907304994.
8
Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
Am J Surg Pathol. 2007 Aug;31(8):1149-60. doi: 10.1097/PAS.0b013e318031ffff.
9
Detection of the ASPSCR1-TFE3 gene fusion in paraffin-embedded alveolar soft part sarcomas.
Histopathology. 2007 Jun;50(7):881-6. doi: 10.1111/j.1365-2559.2007.02693.x.
10
The impact of translocations and gene fusions on cancer causation.
Nat Rev Cancer. 2007 Apr;7(4):233-45. doi: 10.1038/nrc2091. Epub 2007 Mar 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验